Equivac 2in1 Vaccine 1ml Syringe

Description

• Equivac 2in1 is used in the prevention of tetanus due to Clostridium tetani and in the control of strangles due to Streptococcus equi subspecies equi in horses
• Equivac 2in1 is one of a range of Equivac products available for tetanus and strangles treatment and control

• Equivac 2in1 provides a more practical and economical means of vaccinating simultaneously for both tetanus and strangles than purchasing and administering two separate vaccines
• Prevention of tetanus: A single dose of Equivac 2in1 given to an unimmunised horse at the time of wounding or surgery may not prevent tetanus. For short-term prevention of tetanus, Equivac® TAT should also be used. See entry for Equivac TAT 
• Combined Active-Passive Protection: Equivac 2in1 can be administered simultaneously with Equivac TAT. A separate needle and syringe should be used for each product and administration should be on opposite sides of the body. If initiating a primary course the second dose of Equivac 2in1 should be administered 4 to 6 weeks later
• Zoetis offers a guarantee against tetanus infection if horses are vaccinated by veterinarians with Equivac 2in1 in accordance with the guidelines of the Equine Infectious Diseases Advisory Board and the dose is registered with the Hendra Registry

Clinical Use

• See product leaflet for full instructions
• 1 mL injected intra-muscularly. • For primary immunisation of horses against strangles, horses 3 months of age or older should be given 3 doses of vaccine at intervals no less than 2 weeks apart. For ongoing immunisation, booster doses should be given annually, or every 6 months for horses at higher risk of exposure. Equivac® S may be used for strangles vaccination where tetanus inclusion is not warranted
• For primary immunisation of horses against tetanus, horses 3 months of age and older should be given 2 doses at intervals of 4 to 6 weeks, followed by a booster 12 months later. Further boosters for tetanus are recommended by the Equine Infectious Diseases Advisory Board every 12 months for maximal protection against tetanus infection
• The product leaflet should be consulted for guidance as to the use of strangles vaccine in the event of an outbreak
• It is recommended that strangles vaccination be a component of a herd-health biosecurity-focussed management program for the prevention and control of strangles in horses

Human Safety

Additional user safety

Take care to avoid accidental self-injection.

First Aid Statement

If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126.

Registered label warnings

Withholding Periods

Meat (Horses): Zero (0) days

Meat (Cattle, Sheep, Goats, Pigs): Zero (0) days

Milk: Zero (0) days

ESI

ESI not applicable

Side Effects

Allergic reactions such as anaphylaxis occur rarely with biological products and may require appropriate treatment. Transient soft tissue swelling associated with the site of injection of this product has been reported on rare occasions.